GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (OTCPK:ITHUF) » Definitions » EBIT

iAnthus Capital Holdings (iAnthus Capital Holdings) EBIT : $-24.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings EBIT?

iAnthus Capital Holdings's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-4.4 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-24.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. iAnthus Capital Holdings's annualized ROC % for the quarter that ended in Mar. 2024 was -9.24%. iAnthus Capital Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -14.80%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. iAnthus Capital Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -7.77%.


iAnthus Capital Holdings EBIT Historical Data

The historical data trend for iAnthus Capital Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iAnthus Capital Holdings EBIT Chart

iAnthus Capital Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only -289.65 -257.08 -23.08 -412.08 -29.76

iAnthus Capital Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.08 -5.54 -7.76 -6.38 -4.42

Competitive Comparison of iAnthus Capital Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iAnthus Capital Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's EV-to-EBIT falls into.



iAnthus Capital Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iAnthus Capital Holdings  (OTCPK:ITHUF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

iAnthus Capital Holdings's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-17.556 * ( 1 - -24.14% )/( (239.669 + 232.252)/ 2 )
=-21.7940184/235.9605
=-9.24 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

iAnthus Capital Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-17.672/( ( (121.38 + max(-85.255, 0)) + (117.449 + max(-85.474, 0)) )/ 2 )
=-17.672/( ( 121.38 + 117.449 )/ 2 )
=-17.672/119.4145
=-14.80 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.609 + 25.382 + 2.414) - (117.66 + 0 + 0)
=-85.255

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.554 + 24.763 + 4.227) - (121.018 + 0 + 0)
=-85.474

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

iAnthus Capital Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-24.098/310.178
=-7.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iAnthus Capital Holdings EBIT Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


iAnthus Capital Holdings (iAnthus Capital Holdings) Business Description

Traded in Other Exchanges
Address
420 Lexington Avenue, Suite 414, New York, NY, USA, 10170
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
Executives
Proud Richard C. Jr. director, officer: CEO and Director 8253 PARSONS PASS, NEW ALBANY OH 43054
Alexander Shoghi director SUITE 1550, 300 WEST 6TH STREET, AUSTIN TX 78701
John Alexander Paterson director 2 WENDIGO WAY, TORONTO A6 M6S2T9
Gotham Green Partners Llc 10 percent owner 1437 4TH STREET, SANTA MONICA CA 90401
Philippe Faraut officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Kenneth W Gilbert director C/O THE WENDY'S COMPANY, ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Julius Kalcevich officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Robert R Galvin officer: Interim CEO and COO
Senvest Management, Llc director, 10 percent owner, other: (See Remarks) 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Marco Dattanasio director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Scott Herman Cohen director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Zachary Arrick director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Mich J Mathews-spradlin director ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Oasis Investments Ii Master Fund Ltd. 10 percent owner UGLAND HOUSE PO BOX 309, GRAND CAYMAN E9 KY1-1104
Seth Fischer 10 percent owner C/O OASIS MANAGEMENT (HONG KONG) LLC, 21/F MAN YEE BUILDING, 68 DES VOEUX ROAD, CENTRAL K3

iAnthus Capital Holdings (iAnthus Capital Holdings) Headlines